Clinical Evaluation of a Radioimmunoprecipitation Assay for IA-2 Antibody and Comparison of GAD Antibody in Type 1 Diabetes Mellitus
- 1 January 2000
- journal article
- Published by Taylor & Francis in Autoimmunity
- Vol. 32 (2), 79-88
- https://doi.org/10.3109/08916930008994076
Abstract
We evaluated a insulinoma-associated protein (IA-2) antibody assay kit using 125I-labelled recombinant IA-2. IA-2 antibodies were present in patients with early-onset type 1 diabetes mellitus (DM) at frequencies of 74%, 67%, 57%, and 50% for respective periods <1 year, l<years<2, 2&lyears<3, and 3<years<4 after onset. IA-2 antibody frequency was low throughout the DM course as compared with glutamic acid decarboxylase (GAD) antiboby frequency. No one had IA-2 antibody, but 29% still had positive GAD antibody titers after 11 years. Of the patients with 0<years<7 duration, 42% had IA-2 Ab+/GAD Ab+, 9% IA-2 Ab+/GAD Ab-, and 24% IA-2 Ab-/GAD Ab+. Prevalence of IA-2 and GAD antibody in 1243 patients with type 2 DM were 1.5% and 3.1%, respectively, and 1.1% had both. This new IA-2 antibody kit is easy to use and provides a specific, sensitive method for making routine assays. Furthermore, the combined analysis of GAD antibody provides high detection of type 1 DMKeywords
This publication has 25 references indexed in Scilit:
- Autoantibodies to IA-2 in insulin-dependent diabetes mellitus: Measurements with a new immunoprecipitation assayClinica Chimica Acta; International Journal of Clinical Chemistry, 2000
- IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus.Proceedings of the National Academy of Sciences, 1996
- The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2.Proceedings of the National Academy of Sciences, 1995
- Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512).Journal of Clinical Investigation, 1995
- Molecular Cloning and Identification of a Receptor-Type Protein Tyrosine Phosphatase, IA-2, from Human InsulinomaDNA and Cell Biology, 1994
- Detection of pancreatic islet 64,000 M(r) autoantigens in insulin-dependent diabetes distinct from glutamate decarboxylase.Journal of Clinical Investigation, 1993
- Assessment of precision, concordance, specificity, and sensitivity of islet cell antibody measurement in 41 assaysDiabetologia, 1990
- Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylaseNature, 1990
- Precision of the islet-cell antibody assay depends on the pancreasJournal of Clinical Laboratory Analysis, 1990
- ISLET-CELL ANTIBODIES IN DIABETES MELLITUS WITH AUTOIMMUNE POLYENDOCRINE DEFICIENCIESThe Lancet, 1974